A Phase III study found that Santarus and Cosmo Pharmaceuticals' budesonide MMX worked better than a dummy pill at putting patients with mild or moderate active ulcerative colitis in remission after eight weeks. Both 9- and 6-milligram doses of the treatment were well tolerated, the drugmakers said.

Full Story:

Related Summaries